Detection of daptomycin-nonsusceptible strains using the Neo-Sensitab™ prediffusion method

Diagnostic Microbiology and Infectious Disease

Volumn 61, Issue 3, 2008, Pages 315-320

  Katz, Bradley D ^a   Luperchio, Steven A ^a   Thorne, Grace M ^a  

^a CUBIST PHARMACEUTICALS INC   (United States)

Author keywords

Daptomycin; Enterococci; Neo Sensitabs; S. aureus; Susceptibility testing

Indexed keywords

DAPTOMYCIN; NEO-SENSITAB;

AGAR DIFFUSION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; DRUG SENSITIVITY; ENTEROCOCCUS FAECIUM; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 45349095835     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.01.021     Document Type: Article

References (15)

1. Barry A.L. Procedure for testing antimicrobial agents in agar media: theoretical considerations. In: Lorain V. (Ed). Antibiotics in Laboratory Medicine. 2nd ed (1986), Williams & Wilkins, Baltimore 21
2. Bolmstrom A., Engelhardt A., Karlsson A., Ho P., Mills K., Wanger A., and Howe R. Validation of a novel Etest daptomycin gradient with calcium against the CLSI reference using the FDA 510 (k) review criteria for susceptibility test devices. The 105th General Meeting of the American Society of Microbiologists, Atlanta, GA (2005)
3. Clinical and Laboratory Standards Institute. M23-A2, Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline. 2nd ed. (2001), CLSI, Wayne, PA
4. Clinical and Laboratory Standards Institute. M2-A9, Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard. 9th ed. (2006), CLSI, Wayne, PA
5. Clinical and Laboratory Standards Institute. M100-S17, Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement (2007), CLSI, Wayne, PA
6. Gales A.C., Reis A.O., and Jones R.N. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J. Clin. Microbiol. 39 (2001) 183-190
7. Jevitt L.A., Thorne G.M., Traczewski M.M., Jones R.N., McGowan J.E., Tenover F.C., and Brown S.D. Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates. J. Clin. Microbiol. 44 (2006) 3098-3104
8. Koeth L.M., and DiFranco J.M. Comparison of daptomycin Etest MICs with broth microdilution MICs against a challenge set of 58 S. aureus and 44 Enterococcus spp. The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC (2005)
9. Nielsen S.V., and Casals J.B. Detection of decreased susceptibility to glycopeptides in Staphylococcus aureus using tablet (disc) pre-diffusion. The 15th European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen, Denmark (2005)
10. Pfaller M.A., Sader H.S., and Jones R.N. Evaluation of the in vitro activity of daptomycin against 19,615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005). Diagn. Microbiol. Infect. Dis. 57 (2007) 459-465
11. Sader H.S., Fritsche T.R., and Jones R.N. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Antimicrob. Agents Chemother. 50 (2006) 2330-2336
12. Supplement User's Guide. Neo-Sensitabs™ Susceptibility Testing, Supplement (2006), Rosco Diagnostica A/S, Taastrup Denmark
13. Tan T.Y., and Ng L.S. Comparison of three standardized disc susceptibility testing methods for colistin. J. Antimicrob. Chemother. 58 (2006) 864-867
14. Tenover F.C., Lancaster M.V., Hill B.C., Steward C.D., Stocker S.A., Hancock G.A., O'Hara C.M., McAllister S.K., Clark N.C., and Hiramatsu K. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 36 (1998) 1020-1027
15. User's Guide. Neo-Sensitabs™ Susceptibility Testing. 19th ed. (2007), Rosco Diagnostica A/S, Taastrup Denmark